NCT07227168 A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer Status RECRUITING Phase PHASE1
NCT07222657 Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma Status RECRUITING Phase PHASE2
NCT07217704 Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer. Status RECRUITING Phase PHASE3
NCT07187154 The Application of Symptoms Management Program Based on the Patient Reported Outcome After Esophagectomy Status RECRUITING Phase NA
NCT07090499 A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT07059884 Distance-Based Exercise to Preserve Function and Prevent Disability Status RECRUITING Phase NA
NCT07039526 Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer. Status RECRUITING Phase PHASE2
NCT06914011 Circulating Tumor DNA MRD-Guided Adjuvant Therapy for Curatively Resected Locally Advanced Esophageal Squamous Cell Carcinoma Status NOT_YET_RECRUITING Phase PHASE3
NCT06906887 PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer Status RECRUITING Phase PHASE2
NCT06710756 Lead-212 PSV359 Therapy for Patients With Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06695845 A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors Status RECRUITING Phase PHASE2
NCT06476067 Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma Status RECRUITING Phase N/A
NCT06469944 Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06) Status RECRUITING Phase PHASE1/PHASE2
NCT06465069 A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors Status RECRUITING Phase PHASE1
NCT06445972 Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06) Status RECRUITING Phase PHASE1/PHASE2
NCT06293898 Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors Status RECRUITING Phase PHASE1
NCT06172478 A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE2
NCT06123338 A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer Status RECRUITING Phase PHASE2